Best Blenrep (Belantamab) Medicine in India

Blenrep (Belantamab) is a targeted anticancer treatment used in the management of multiple myeloma. It is an antibody-drug conjugate that targets B-cell maturation antigen (BCMA), a protein found on multiple myeloma cells. By binding to BCMA and delivering its cytotoxic component to abnormal cells, it helps destroy cancer cells and slow the progression of the disease.

Blenrep (Belantamab) is administered by a healthcare professional through an intravenous infusion. The dose and treatment schedule are determined by your doctor based on your condition, previous treatments, and response to therapy. Regular medical appointments, blood tests, and eye examinations may be required during treatment to monitor your health and identify potential side effects.

Common side effects of Blenrep (Belantamab) may include changes in vision, eye-related problems, reduced blood cell counts, nausea, fatigue, fever, infusion-related reactions, and changes in liver function. Inform your doctor if you notice blurred vision, dry eyes, eye discomfort, or other changes in eyesight. Before starting treatment, tell your doctor about your medical conditions and all medicines or supplements you are taking. Your doctor may monitor your blood counts and eye health throughout treatment. Pregnant women should consult their doctor before treatment, as Belantamab Mafodotin may cause harm to an unborn baby.

Treatment of Multiple Myeloma

Blenrep (Belantamab) helps target and destroy BCMA-positive multiple myeloma cells, which can slow cancer growth and progression. It may help reduce the number of abnormal plasma cells and support disease control in eligible patients.

Some side effects of Blenrep (Belantamab) may improve as your body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Blenrep (Belantamab)

Blenrep (Belantamab) is administered by a healthcare professional through an intravenous infusion. The dose and treatment schedule are determined by your doctor based on your condition and response to treatment. Regular eye examinations and blood tests may be required during treatment. Do not change the prescribed dose or treatment schedule without consulting your doctor.

Blenrep (Belantamab) works by targeting B-cell maturation antigen (BCMA) found on multiple myeloma cells. After binding to BCMA, it delivers its active component into the cancer cells, causing their destruction. This helps reduce abnormal myeloma cells and may slow the progression of multiple myeloma.

• Maintain the unopened vial under refrigeration at 2°C to 8°C.
• Avoid freezing the vial or exposing it to freezing temperatures.
• Retain the vial in its original carton to shield it from light.
• After reconstitution and dilution, the solution may be kept for up to 6 hours at room temperature or 24 hours under refrigeration.

Alcohol CONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol during treatment with Blenrep (Belantamab).

Pregnancy CONSULT YOUR DOCTOR

Blenrep (Belantamab) may harm an unborn baby. Use effective contraception during treatment as advised by your doctor.

Breastfeeding CONSULT YOUR DOCTOR

Avoid breastfeeding during treatment with Blenrep (Belantamab) and for the recommended period after the final dose. Consult your doctor for guidance.

Driving CONSULT YOUR DOCTOR

Blenrep (Belantamab) may cause vision changes or other effects that can affect driving. Avoid driving if your vision or alertness is affected.

Kidney CAUTION

Inform your doctor if you have kidney problems before receiving Blenrep (Belantamab). Your doctor may monitor your kidney function during treatment.

Liver CAUTION

Tell your doctor if you have liver disease. Liver function may be monitored during treatment with Blenrep (Belantamab).

• Attend all scheduled eye examinations and report blurred vision, eye pain, dryness, or any other vision changes promptly.
• Your doctor may regularly monitor your blood counts and liver function during treatment with Blenrep (Belantamab).
• Avoid driving or operating machinery if you experience vision changes or symptoms that affect your alertness.
• Inform your doctor about all medicines, vitamins, herbal products, and dietary supplements you are taking to help prevent possible drug interactions.
• Contact your doctor promptly if you develop fever, unusual bleeding, severe fatigue, or other signs of infection or low blood cell counts.
• Read More About - Blenrep (Belantamab) from Pharma Five.

Pharma Five, may facilitate patients in importing Blenrep (Belantamab) in small quantities for personal medical use. To initiate the import process, the applicant is required to submit Form 12A along with a prescription from a Registered Medical Practitioner (RMP).

Pharma Five offers professional pharmaceutical facilitation services to assist patients with access to Blenrep (Belantamab) and other specialized pharmaceutical products through the required import process. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.